TP53 and cancer: Although in human cancers, mutations in TP73 are less frequent than those in TP53, genetic aberrations of TP73 were, nevertheless, reported in PDAC, and previous studies already showed that loss of Tap73 induced spontaneous tumor development because of enhanced genomic instability [14].